We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
CTMX | CytomX Therapeutics Inc | 5.14 | 3.51 | 215.34% | 206,720,445 |
SYT | SYLA Technologies Company Ltd | 3.375 | 1.92 | 131.16% | 12,121,225 |
RGF | Real Good Food Company Inc | 0.49 | 0.2064 | 72.78% | 4,668,052 |
BCAB | BioAtla Inc | 3.39 | 1.14 | 50.33% | 4,096,680 |
PBM | Psyence Biomedical Ltd | 1.2099 | 0.3105 | 34.52% | 5,857,192 |
IMCC | IM Cannabis Corporation | 1.1514 | 0.2914 | 33.88% | 40,877,979 |
APVO | Aptevo Therapeutics Inc | 0.95 | 0.2393 | 33.67% | 6,266,588 |
SRDX | SurModics Inc | 33.318 | 7.63 | 29.69% | 256,570 |
MDIA | Mediaco Holding Inc | 2.26 | 0.50 | 28.41% | 442,327 |
RCKY | Rocky Brands Inc | 32.80 | 7.03 | 27.28% | 210,556 |
CYCC | Cyclacel Pharmaceuticals Inc | 2.6802 | 0.5602 | 26.42% | 17,564,410 |
TORONTO and GLIL YAM, Israel, May 1, 2024 /PRNewswire/ --Â IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2024 ended March 31, 2024, on Wednesday, May 8, 2024, before the market opens.
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March 31, 2024, and updated financial guidance for its fiscal year ending September 30, 2024.
Rocky Brands, Inc. (NASDAQ: RCKY), a leading designer, manufacturer and marketer of premium quality footwear and apparel, today announced the signing of a definitive debt refinance agreement with Bank of America, as agent. The new agreement, which amends and restates the Company’s existing revolving credit facility, will serve to enhance the Company’s cash flow and liquidity profile while permitting a more simplified capital structure.
ANDOVER, Mass., April 30, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2024.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
FNMA | Fannie Mae | 118 | |
RDGL | Vivos Inc | 93 | |
AABB | Asia Broadband Inc | 95 | |
4 | VPLM | Voip Pal Com Inc | 30 |
5 | ELTP | Elite Pharmaceuticals Inc | 28 |
6 | RNVA | Rennova Health Inc | 84 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 57,310.34 | -927.39 | -1.59% | 1.12T | 8,874,352,380 |
ETH | Ethereum | 2,906.47 | -62.87 | -2.12% | 348.87B | 3,557,396,091 |
USDT | Tether USD | 0.99909 | 0.00053 | 0.05% | 97.75B | 269,714,200 |
BNB | Binance Coin | 545.90 | -15.04 | -2.68% | 86.22B | 458,828,411 |
SOL | Solana | 129.14 | -5.40 | -4.01% | 56.82B | 1,716,367,145 |
STETH | stETH | 2,893.19 | -74.07 | -2.50% | 28.31B | 13,579,676 |
USDC | USD Coin | 1.00 | 0.0001 | 0.01% | 28.07B | 967,238,395 |
XRP | Ripple | 0.510 | -0.0065 | -1.26% | 27.79B | 444,628,775 |
DOGE | Dogecoin | 0.12531 | -0.00471 | -3.62% | 17.85B | 713,854,466 |
TONCOIN | Wrapped TON Coin | 4.71 | -0.167023 | -3.43% | 16.25B | 125,636,465 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions